Imatinib and Trametinib for KRAS-mutated Solid Tumor

Clinical trial NCT06962254 · RECRUITING

Trial details

NCT number: NCT06962254
Sponsor: China Medical University Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2025-05-10
Primary completion: 2028-03-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.